Spondylitis Association of America Announces Virtual Event to Empower Community Living With Chronic Disease

The Spondylitis Association of America (SAA) announced the launch of its 6th Annual Global Spondyloarthritis Summit, scheduled for May 3-4, 2024. This virtual event aims to educate and empower individuals affected by Ankylosing Spondylitis (AS) and other spondyloarthritis diseases. Over 3.2 million Americans with AS, a condition involving spinal inflammation, will have access to information about the latest treatments and research developments through this summit.

The program includes sessions led by top experts in rheumatology and related health care fields, covering topics such as advanced treatment options, strategies for managing daily fatigue, the role of precision medicine, and the potential impact of artificial intelligence on the diagnosis and treatment of spondyloarthritis. Attendees can participate in live Q&A sessions, breakout discussions, and networking forums, enhancing opportunities for community support and information exchange. Industry support from companies like UCB and AbbVie has been crucial in making this summit possible.